Insights into White Matter Defect in Huntington’s Disease
Open Access
Abstract
Huntington’s disease (HD) is an autosomal-dominant inherited progressive neurodegenerative disorder. It is caused by a CAG repeat expansion in the Huntingtin gene that is translated to an expanded polyglutamine (PolyQ) repeat in huntingtin protein. HD is characterized by mood swings, involuntary movement, and cognitive decline in the late disease stage. HD patients often die 15–20 years after disease onset. Currently, there is no cure for HD. Due to the striking neuronal loss in HD, most studies focused on the investigation of the predominantly neuronal degeneration in specific brain regions. However, the pathology of the white matter area in the brains of HD patients was also reported by clinical imaging studies, which showed white matter abnormalities even before the clinical onset of HD. Since oligodendrocytes form myelin sheaths around the axons in the brain, white matter lesions are likely attributed to alterations in myelin and oligodendrocyte-associated changes in HD. In this review, we summarized the evidence for white matter, myelin, and oligodendrocytes alterations that were previously observed in HD patients and animal models. We also discussed potential mechanisms for white matter changes and possible treatment to prevent glial dysfunction in HD.Keywords
Funding Information
- The National Natural Science Foundation of China (81830032, 82071421, 31872779, 81901289, 202007030008, 2021ZT09Y007, 2020B121201006, 2018B030337001)
- Guangzhou Key Research Program on Brain Science (81830032, 82071421, 31872779, 81901289, 202007030008, 2021ZT09Y007, 2020B121201006, 2018B030337001)
- Department of Science and Technology of Guangdong Province (81830032, 82071421, 31872779, 81901289, 202007030008, 2021ZT09Y007, 2020B121201006, 2018B030337001)
This publication has 96 references indexed in Scilit:
- An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicityCell Death & Disease, 2012
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- A putative functional role for oligodendrocytes in mood regulationTranslational Psychiatry, 2012
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's DiseaseMolecular Therapy, 2011
- Cortical Metabolites as Biomarkers in the R6/2 Model of Huntington's DiseaseJournal of Cerebral Blood Flow & Metabolism, 2011
- Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophreniaProgress in Neurobiology, 2011
- An ovine transgenic Huntington's disease modelHuman Molecular Genetics, 2010
- Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptomsProceedings of the National Academy of Sciences, 2009
- Gray and white matter changes associated with tool-use learning in macaque monkeysProceedings of the National Academy of Sciences, 2009
- Towards a transgenic model of Huntington’s disease in a non-human primateNature, 2008